D-0081-2019 Class I Ongoing
FDA drug recall D-0081-2019 was initiated by Hetero Labs Limited Unit V on Aug 15, 2018 and is designated Class I. Reason for recall: Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg tablets may contain 90 tablets of Losartan Potassium 50 mg. The recall status is ongoing. Affected quantity: 98016 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 3, 2018
- Initiation Date
- Aug 15, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 98016 bottles
Product description
Montelukast Sodium Tablets 10 mg, 30-count bottle, Rx Only, By: Hetero Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, Manfuactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, NDC 31722-726-30
Reason for recall
Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg tablets may contain 90 tablets of Losartan Potassium 50 mg.
Distribution pattern
U.S.A. Nationwide
Code information
Lot #: MON17384, Exp 12/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0081-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026